Cargando...
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat
Idiopathic pulmonary fibrosis (IPF) is a progressive disease with a dismal prognosis. The average life expectancy of untreated patients with IPF is only 3 to 4 years. Decline in forced vital capacity (FVC) in patients with IPF appears to be almost linear, with patients with well-preserved FVC at bas...
Gardado en:
| Publicado en: | Respir Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6731623/ https://ncbi.nlm.nih.gov/pubmed/31492155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-019-1161-4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|